Market Price

250.73 

4.62 1.9%

as of Feb 26 '21

52 Week Range:

144.07 284.67


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. Additionally, the company offers Trace, a patient data visualization and reporting software for Masimo Root and Radical-7 monitors. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, home care providers, long term care facilities, veterinarians, and consumers. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '12 Dec '13 Dec '14 Jan '15 Oct '15 Jan '16 Oct '16 Dec '17 Dec '18 Dec '19 Jan '21
Equity (BVPS) 4.77
5.54
5.40
5.35
6.64
13.89
17.19
20.64
25.70
growth rate 16.1% -2.5% -0.5% 11.4% 109.2% 23.8% 20.1% 24.5%
Earnings BIT 83.82
75.73
93.18
111.24
165.95
183.79
208.47
221.22
255.35
growth rate -9.7% 10.9% 9.3% 49.2% 10.8% 13.4% 6.1% 15.4%
Avg.PE 19.69
28.82
27.74
25.94
14.89
13.80
49.82
43.85
growth rate 46.4% -3.8% -3.3% -24.2% -7.3% 261.0% -12.0%
ROA 16.78
14.33
14.45
14.28
42.28
15.21
18.74
15.38
15.46
growth rate -14.6% 0.8% -0.6% 72.1% -64.0% 23.2% -17.9% 0.5%
ROE 22.65
19.48
22.93
28.65
71.96
20.77
23.10
18.36
18.66
growth rate -14.0% 17.7% 11.8% 58.5% -71.1% 11.2% -20.5% 1.6%
ROIC 22.56
19.35
19.08
18.67
58.90
20.77
23.10
16.97
17.91
growth rate -14.2% -1.4% -1.1% 77.6% -64.7% 11.2% -26.5% 5.5%
Cur. Ratio 2.45
2.62
2.54
2.26
2.30
3.72
5.32
5.78
4.71
growth rate 6.9% -3.1% -5.7% 0.9% 61.7% 43.0% 8.7% -18.5%
Quick Ratio 1.64
1.73
1.72
1.66
1.89
2.93
4.56
4.96
3.52
growth rate 5.5% -0.6% -1.8% 6.7% 55.0% 55.6% 8.8% -29.0%
Leverage 1.38
1.34
1.85
2.18
1.46
1.29
1.19
1.20
1.22
growth rate -2.9% 38.1% 8.6% -18.2% -11.6% -7.8% 0.8% 1.7%
Balance Sheet Dec '12 Dec '13 Dec '14 Jan '15 Oct '15 Jan '16 Oct '16 Dec '17 Dec '18 Dec '19 Jan '21
Acct.Receivable 87.95
96.40
78.60
88.48
109.55
135.27
119.93
166.84
181.38
growth rate 9.6% -9.7% 6.1% 23.8% 23.5% -11.3% 39.1% 8.7%
Acct.Payable 70.21
82.92
38.05
25.87
34.34
33.78
40.39
54.55
64.06
growth rate 18.1% -32.3% -17.6% 32.8% -1.6% 19.6% 35.1% 17.4%
Cur.Assets 219.35
271.80
297.08
299.14
507.23
559.70
789.28
996.06
1,101.17
growth rate 23.9% 4.6% 0.4% 69.6% 10.3% 41.0% 26.2% 10.6%
Total Assets 374.66
438.66
565.01
601.74
820.53
905.44
1,154.82
1,396.13
1,712.55
growth rate 17.1% 13.5% 3.2% 36.4% 10.4% 27.5% 20.9% 22.7%
Cash 71.55
95.47
134.45
132.32
305.97
315.30
552.49
567.69
641.45
growth rate 33.4% 18.7% -0.8% 131.2% 3.1% 75.2% 2.8% 13.0%
Inventory 47.36
56.81
69.72
62.04
72.54
92.26
94.73
115.87
215.95
growth rate 20.0% 10.8% -5.7% 16.9% 27.2% 2.7% 22.3% 86.4%
Cur.Liabilities 89.54
103.79
123.89
132.63
220.37
129.65
146.56
172.22
233.84
growth rate 15.9% 9.3% 3.5% 66.2% -41.2% 13.0% 17.5% 35.8%
Liabilities 101.58
112.19
257.27
326.02
260.29
181.41
185.75
228.25
304.91
growth rate 10.5% 51.4% 12.6% -20.2% -30.3% 2.4% 22.9% 33.6%
LT Debt 0.06
0.23
125.00
185.00
growth rate 275.0% 2,257.0% 21.7%
Equity 273.08
326.47
306.00
275.42
560.24
724.03
969.07
1,167.87
1,407.66
growth rate 19.6% -3.2% -5.1% 103.4% 29.2% 33.8% 20.5% 20.5%
Common Shares 58.00
57.00
56.00
54.00
53.00
56.00
56.00
57.00
0.06
growth rate -1.7% -1.8% -1.8% -0.9% 5.7% 0.0% 1.8% -99.9%
Cash Flow Statement Dec '12 Dec '13 Dec '14 Jan '15 Oct '15 Jan '16 Oct '16 Dec '17 Dec '18 Dec '19 Jan '21
Capital Expenditures 10.52
9.43
75.06
50.39
19.71
43.68
17.13
68.38
72.55
growth rate -10.4% 182.2% -18.1% -60.9% 121.7% -60.8% 299.3% 6.1%
Cash Dividends 57.28
0.00
growth rate -100.0%
Cash From OA 75.12
55.10
95.61
117.21
419.13
56.06
239.53
221.64
210.96
growth rate -26.7% 31.7% 10.7% 257.6% -86.6% 327.3% -7.5% -4.8%
FCF per Share 1.04
0.92
0.31
0.55
2.23
5.24
3.57
2.63
2.38
growth rate -11.5% -66.3% 33.2% 101.4% 135.0% -31.9% -26.3% -9.5%
Sale Purchase of Stock -24.63
-16.50
4.68
28.29
37.29
62.21
growth rate 0.0% 100.0% 145.8% 31.8% 66.8%
FCF 61.00
41.00
17.00
20.55
60.00
66.81
392.00
9.00
217.00
149.00
131.00
growth rate -32.8% -58.5% 20.9% 191.9% 11.4% 486.7% -97.7% 2,311.1% -31.3% -12.1%
Income Statement Dec '12 Dec '13 Dec '14 Jan '15 Oct '15 Jan '16 Oct '16 Dec '17 Dec '18 Dec '19 Jan '21
Sales 493.23
547.25
580.04
623.21
712.90
790.25
858.29
937.84
1,143.74
growth rate 11.0% 3.0% 3.7% 14.4% 10.9% 8.6% 9.3% 22.0%
Op.Income 62.27
58.38
93.18
111.24
165.95
183.79
208.47
221.22
255.35
growth rate -6.3% 26.3% 9.3% 49.2% 10.8% 13.4% 6.1% 15.4%
IBT 83.82
75.73
102.04
116.35
433.52
185.80
213.78
234.17
263.74
growth rate -9.7% 16.1% 6.8% 272.6% -57.1% 15.1% 9.5% 12.6%
Net Income 62.27
58.38
72.52
83.30
311.10
124.79
193.54
196.22
240.30
growth rate -6.3% 11.5% 7.2% 273.5% -59.9% 55.1% 1.4% 22.5%
EPS 1.07
1.02
1.30
1.55
5.85
2.23
3.45
3.44
4.14
growth rate -4.7% 27.5% 9.2% 94.3% -61.9% 54.7% -0.3% 20.4%
Gross Profit 326.25
358.83
390.78
419.68
478.34
522.03
574.89
629.17
743.07
growth rate 10.0% 4.4% 3.6% 14.0% 9.1% 10.1% 9.4% 18.1%
R&D 47.08
55.63
56.58
55.72
57.69
65.23
81.01
93.30
118.66
growth rate 18.2% 0.9% -0.8% 3.5% 13.1% 24.2% 15.2% 27.2%

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Jan '21
Earnings BIT 61.56
68.51
62.25
59.70
64.90
growth rate 11.3% -9.2% -4.1% 8.7%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Jan '21
Acct.Receivable 166.84
187.61
217.20
182.93
181.38
growth rate 12.5% 15.8% -15.8% -0.8%
Acct.Payable 54.55
49.11
89.55
89.53
64.06
growth rate -10.0% 82.4% 0.0% -28.5%
Cur.Assets 996.06
980.16
1,092.61
1,158.97
1,101.17
growth rate -1.6% 11.5% 6.1% -5.0%
Total Assets 1,396.13
1,474.55
1,635.63
1,713.14
1,712.55
growth rate 5.6% 10.9% 4.7% 0.0%
Cash 567.69
605.92
631.88
669.06
641.45
growth rate 6.7% 4.3% 5.9% -4.1%
Inventory 115.87
115.98
155.15
204.78
215.95
growth rate 0.1% 33.8% 32.0% 5.5%
Cur.Liabilities 172.22
157.29
227.56
232.75
233.84
growth rate -8.7% 44.7% 2.3% 0.5%
Liabilities 228.25
221.27
291.09
298.34
304.91
growth rate -3.1% 31.6% 2.5% 2.2%
LT Debt
growth rate
Equity 1,167.87
1,253.28
1,344.55
1,414.80
1,407.66
growth rate 7.3% 7.3% 5.2% -0.5%
Common Shares 0.05
0.05
0.06
0.06
0.06
growth rate 0.0% 1.9% 0.0% 0.0%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Jan '21
Capital Expenditures 12.31
37.00
14.26
8.75
12.53
growth rate 200.6% -61.5% -38.6% 43.2%
Cash Dividends
growth rate
Cash From OA 70.22
42.36
63.71
40.49
64.42
growth rate -39.7% 50.4% -36.5% 59.1%
Sale Purchase of Stock
growth rate
FCF 57.91
5.35
49.45
31.73
51.89
growth rate -90.8% 824.1% -35.8% 63.5%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Jan '21
Sales 247.51
269.63
300.95
278.11
295.05
growth rate 8.9% 11.6% -7.6% 6.1%
Op.Income 61.56
68.51
62.25
59.70
64.90
growth rate 11.3% -9.2% -4.1% 8.7%
IBT 64.37
72.36
63.63
61.06
66.70
growth rate 12.4% -12.1% -4.0% 9.3%
Net Income 52.92
64.46
55.77
49.41
70.67
growth rate 21.8% -13.5% -11.4% 43.0%
EPS
growth rate
Gross Profit 166.92
185.63
191.58
178.93
186.93
growth rate 11.2% 3.2% -6.6% 4.5%
R&D 23.42
27.24
30.88
28.85
31.69
growth rate 16.3% 13.4% -6.6% 9.8%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (71.69)

YOY Growth Grade:

D (48.93)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 60.56 60.56 58.04
EPS / Growth 21.7% 4.14 11.9%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 24.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 11.9% 19.4% 19.4%
Future PE 23.80 52.45 52.45
Future EPS 12.74 24.34 24.34
Value Price
MOS %
74.97
-70.1%
315.58
25.9%
315.58
25.9%
MOS Price 37.49 157.79 157.79
IRT 17.84 13.43 13.43

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.